ASC-J9
| CAS No. | 917813-54-8 | Cat. No. | BCP06115 |
| Name | ASC-J9 | ||
| Synonyms | ASC J9;ASCJ9; | ||
| Formula | C23H24O6 | M. Wt | 396.43 |
| Description | ASC-J9 suppresses castration-resistant prostate cancer growth via degradation of full-length and splice variant androgen receptors. Research results suggested that targeting both fAR- and AR3-mediated PCa growth by ASC-J9 may represent the novel therapeutic approach to suppress castration-resistant PCa. ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. | ||
| Pathways | Hormone Pathay | ||
| Targets | Androgen Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.